The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Cytochromes P450, Drugs, and Diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Self-citationClinical importance of the cytochromes P450
Nebert, D. W., & Russell, D. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11203-7 · Cited by 1,414
Aithal, G. P., Day, C. P., Kesteven, P. J., & Daly, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04474-2 · Cited by 1,243
POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
Mahgoub, A., Dring, L. G., Idle, J. R., Lancaster, R., & Smith, R. L. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91430-1 · Cited by 1,183
Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects
Guengerich, F. P., Kim, D. H., & Iwasaki, M. (1991) · Chemical Research in Toxicology · doi:10.1021/tx00020a008 · Cited by 1,169
Self-citationOxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes
Guengerich, F. P., & Shimada, T. (1991) · Chemical Research in Toxicology · doi:10.1021/tx00022a001 · Cited by 1,000
Self-citationSt. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
Moore, L. B., Goodwin, B., Jones, S. A., Wisely, G. B., Serabjit-Singh, C. J., Willson, T. M., Collins, J. L., & Kliewer, S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130155097 · Cited by 947
Ding, X., & Kaminsky, L. S. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140251 · Cited by 822
Summary of information on human CYP enzymes: human P450 metabolism data
Rendic, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 820
Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada, T., Hayes, C. L., Yamazaki, H., et al. (1996) · PubMed · Cited by 793
Guengerich, F. P. (1995) · Cytochrome P450 · doi:10.1007/978-1-4757-2391-5_14 · Cited by 728
Self-citationLeclerc, S., Garnier, M., Hoessel, R., Marko, D., Bibb, J. A., Snyder, G. L., Greengard, P., Biernat, J., Wu, Y.-Z., Mandelkow, E.-M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m002466200 · Cited by 723
Stoilov, I. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.4.641 · Cited by 647
Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M. L., Sjöqvist, F., & Ingelman-Sundberg, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11825 · Cited by 644
17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.
Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., & Sutter, T. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9776 · Cited by 632
Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
Goldstein, J. A. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01499.x · Cited by 617
Aryl Hydrocarbon Hydroxylase Inducibility and Bronchogenic Carcinoma
Kellermann, G., Shaw, C. R., & Luyten-Kellerman, M. (1973) · New England Journal of Medicine · doi:10.1056/nejm197311012891802 · Cited by 591
Amirimani, B., Walker, A. H., Weber, B. L., & Rebbeck, T. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1588 · Cited by 465
Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy.
Guengerich, F. P. (1988) · PubMed · Cited by 455
Self-citationThe Ah Locus: Genetic Differences in Toxicity, Cancer, Mutation, and Birth Defects
Nebert, D. W. (1989) · Critical Reviews in Toxicology · doi:10.3109/10408448909017908 · Cited by 453
Nakamura, K., Goto, F., Ray, W. A., McAllister, C. B., Jacqz, E., Wilkinson, G. R., & Branch, R. A. (1985) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1985.194 · Cited by 452
Nicotine metabolism defect reduces smoking
Pianezza, M. L., Sellers, E. M., & Tyndale, R. F. (1998) · Nature · doi:10.1038/31623 · Cited by 432
Fu, G. K., Lin, D., Zhang, M. Y. H., Bikle, D. D., Shackleton, C. H. L., Miller, W. L., & Portale, A. A. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.13.0035 · Cited by 398
Nomenclature for human CYP2D6 alleles
Daly, A. K., Brockmoller, J., Broly, F., Eichelbaum, M., Evans, W. E., Gonzalez, F. J., Huang, J. D., Idle, J. R., Ingelman-Sundberg, M., Ishizaki, T., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00001 · Cited by 396
Lang, N. P., Butler, M. A., Massengill, J., Lawson, M., Stotts, R. C., Hauer‐Jensen, M., & Kadlubar, F. F. (1994) · PubMed · Cited by 388
Buters, J. T. M., Sakai, S., Richter, T., Pineau, T., Alexander, D. L., Savas, U., Doehmer, J., Ward, J. M., Jefcoate, C. R., & Gonzalez, F. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1977 · Cited by 383
Metabolic oxidation phenotypes as markers for susceptibility to lung cancer
Ayesh, R., Idle, J. R., Ritchie, J. C., Crothers, M. J., & Hetzel, M. R. (1984) · Nature · doi:10.1038/312169a0 · Cited by 383
Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., Borgers, M., Ramaekers, F. C. S., Odds, F. C., & Vanden Bossche, H. (1999) · Microbiology · doi:10.1099/00221287-145-10-2701 · Cited by 382
Su, T., Bao, Z., Zhang, Q., Smith, T. J., Hong, J., & Ding, X. (2000) · PubMed · Cited by 339
Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s
Waxman, D. J., Lapenson, D. P., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., & Korzekwa, K. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90602-f · Cited by 324
Distlerath, L. M., Reilly, P. E., Martin, M. V., Davis, G. G., Wilkinson, G. R., & Guengerich, F. P. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39456-5 · Cited by 319
Self-citationGenetic association between sensitivity to warfarin and expression of CYP2C9*3
Steward, D. J., Haining, R. L., Henne, K. R., Davis, G., Rushmore, T. H., Trager, W. F., & Rettie, A. E. (1997) · Pharmacogenetics · doi:10.1097/00008571-199710000-00004 · Cited by 303
Westlind, A., Löfberg, L., Tindberg, N., Andersson, T. B., & Ingelman-Sundberg, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0752 · Cited by 300
On the mechanism of prostacyclin and thromboxane A2 biosynthesis
Hecker, M., & Ullrich, V (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31235-8 · Cited by 286
Shimada, T., Iwasaki, M., Martin, M. V., & Guengerich, F. P. (1989) · PubMed · Cited by 265
Self-citationCYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates
Takanashi, K., Tainaka, H., Kobayashi, K., Yasumori, T., Hosakawa, M., & Chiba, K. (2000) · Pharmacogenetics · doi:10.1097/00008571-200003000-00001 · Cited by 261
Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450.
Guengerich, F. P. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13356-7 · Cited by 237
Self-citationIdentification and functional characterization of eight CYP3A4 protein variants.
Eiselt, R., Domanski, T. L., Zibat, A., Mueller, R., Presecan, E., Hustert, E., Zanger, U. M., Brockmöller, J., Klenk, H., Meyer, U., et al. (2001) · Pharmacogenetics · doi:10.1097/00008571-200107000-00008 · Cited by 234
Ball, S. E., Scatina, J., Kao, J., Ferron, G. M., Fruncillo, R., Mayer, P., Weinryb, I., Guida, M., Hopkins, P. J., Warner, N., et al. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70037-8 · Cited by 233
Chou, W. H., Yan, F.-X., de Leon, J., Barnhill, J., Rogers, T., Cronin, M., Pho, M., Xiao, V., Ryder, T. B., Liu, W. W., et al. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00019 · Cited by 226
Cytochrome p450 enzymes in the generation of commercial products
Guengerich, F. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd792 · Cited by 225
Self-citationComparison of P450s from human and fugu: 420 million years of vertebrate P450 evolution
Nelson, D. R. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00553-2 · Cited by 193
Cytochrome P450 pathways of arachidonic acid metabolism
Kroetz, D. L., & Zeldin, D. C. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00007 · Cited by 193
Yamazaki, H., Shaw, P. M., Guengerich, F. P., & Shimada, T. (1998) · Chemical Research in Toxicology · doi:10.1021/tx970217f · Cited by 182
Self-citationGenetic metabolic polymorphisms and the risk of cancer: a review of the literature
D'errico, A., Taioli, E., Chen, X., & Vineis, P. (1996) · Biomarkers · doi:10.3109/13547509609079352 · Cited by 178
Yamazaki, H., Shibata, A., Suzuki, M., Nakajima, M., Shimada, N., Guengerich, F. P., & Yokoi, T. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14927-6 · Cited by 161
Self-citationGenetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
Ariyoshi, N., Miyamoto, M., Umetsu, Y., Kunitoh, H., Dosaka‐Akita, H., Sawamura, Y.-I., Yokota, J., Nemoto, N., Sato, K., & Kamataki, T. (2002) · PubMed · Cited by 155
Unwanted pregnancy on self‐medication with St John's wort despite hormonal contraception
Schwarz, U. I., Büschel, B., & Kirch, W. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01716.x · Cited by 142
Chun, Y., Kim, S., Kim, D., et al. (2001) · PubMed · Cited by 137
Bolt, H. M., Kappus, H., & Bolt, M. (1975) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562654 · Cited by 136
Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system
Makita, K., Falck, J. R., & Capdevila, J. H. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.13.8940291 · Cited by 131
The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro
Yaşar, Ü., Eliasson, E., Forslund‐Bergengren, C., Tybring, G., Gadd, M., Sjöqvist, F., & Dahl, M. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-001-0376-7 · Cited by 115
Ieiri, I., Kubota, T., Urae, A., Kimura, M., Wada, Y., Mamiya, K., Yoshioka, S., Irie, S., Amamoto, T., Nakamura, K., et al. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90004-1 · Cited by 112
Human cytochrome P450s: selectivity and measurement in vivo
Smith, D. A., ABEL, S. M., Hyland, R., & Jones, B. C. (1998) · Xenobiotica · doi:10.1080/004982598238859 · Cited by 105
Uematsu, F., Ikawa, S., Kikuchi, H., Sagami, I., Kanamaru, R., Abé, T., Satoh, K., Motomiya, M., & Watanabe, M. (1994) · Pharmacogenetics · doi:10.1097/00008571-199404000-00002 · Cited by 104
Study of P450 function using gene knockout and transgenic mice
Gonzalez, F. J., & Kimura, S. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00364-8 · Cited by 102
Purification of human liver cytochrome P-450 and comparison to the enzyme isolated from rat liver
Wang, P., Mason, P. S., & Guengerich, F. P. (1980) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(80)90274-x · Cited by 86
Self-citationRe: Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4
Ando, Y., Tateishi, T., Sekido, Y., Yamamoto, T., Satoh, T., Hasegawa, Y., Kobayashi, S., Katsumata, Y., Shimokata, K., & Saito, H. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1587 · Cited by 85
Inhibition of Terfenadine Metabolism
Kivistö, K. T., Neuvonen, P. J., & Klotz, U. E. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427010-00001 · Cited by 84
Aromatase inhibition and its pharmacologic implications
Brodie, A. M. H. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90337-5 · Cited by 75
Shimada, T., Watanabe, J. A., Inoue, K., et al. (2001) · Xenobiotica · doi:10.1080/00498250110043490 · Cited by 74
Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with ST JOHN???S wort
Bolley, R., lke, C. Z., Kammerl, M., Fischereder, M., & Kr�mer, B. K. (2002) · Transplantation · doi:10.1097/00007890-200203270-00035 · Cited by 72
Grapefruit juice—terfenadine single-dose interaction: Magnitude, mechanism, and relevance*
Rau, S. E., Bend, J. R., Arnold, J. M. O., Tran, L. T.-N., Spence, J. D., & Bailey, D. G. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90190-9 · Cited by 68
CYP4B1 Is a Possible Risk Factor for Bladder Cancer in Humans
Imaoka, S., Yoneda, Y., Sugimoto, T., Hiroi, T., Yamamoto, K., Nakatani, T., & Funae, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3740 · Cited by 68
Yu, A., Granvil, C. P., Haining, R. L., Krausz, K. W., Corchero, J., Kupfer, A., Idle, J. R., & Gonzalez, F. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043786 · Cited by 63
Influence of oxidation polymorphism on phenformin kinetics and dynamics
Oates, N. S., Shah, R. R., Idle, J. R., & Smith, R. L. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.257 · Cited by 62
Determination of drug-metabolizing enzyme activity in vivo : pharmacokinetic and statistical issues
Tucker, G. T., Rostami‐Hodjegan, A., & JACKSON, P. R. (1998) · Xenobiotica · doi:10.1080/004982598238895 · Cited by 46
Cited by
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279
Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1
Gonzalez, F. J. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.04.021 · Cited by 555
REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION
Aitken, A. E., Richardson, T. A., & Morgan, E. T. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141059 · Cited by 448
Role of Cytochrome P450 Enzymes in Plant Stress Response
Pandian, B. A., Sathishraj, R., Djanaguiraman, M., Prasad, P. V. V., & Jugulam, M. (2020) · Antioxidants · doi:10.3390/antiox9050454 · Cited by 447
Enzymatic hydroxylation of aromatic compounds
Ullrich, R., & Hofrichter, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6362-1 · Cited by 348
Metadata
- Authors
- Guengerich, F. P.
- Venue
- Molecular Interventions
- Publisher
- CLOCKSS Archive
- Published
- 2003-06-01
- Volume
- 3
- Issue
- 4
- Pages
- 194-204
- ISSN
- 1534-0384 (ISSN-L)
- OpenAlex
- W2140656258
- Cited by
- 378
- References
- 67
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.